Highly Effective Preventive Treatments for HIV

The hosts explore the latest study on preventive treatments for HIV, including pre-exposure prophylaxis (PrEP) drugs such as Travata, Discovii, and Apertude. They discuss the highly effective new drug lenacapavir, which boasts a 100% success rate in clinical trials and requires just two injections per year, offering potential benefits in user compliance and reduced stigma, particularly for high-risk populations like young women in South Africa.